Summary : The initiative will catalyse discovery and early development of antiviral medicines for future…
Tag:
Therapy
-
-
Sanofi Inc.
Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria
by adminSummary : Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous…
-
ChemIntelligenceGlobal Market
Syniverse Is First to Offer a Cloud-Native, Hyperscale Digital Communications and Messaging Platform for Enterprises: Syniverse’s Hyperscale Communications Platform
by adminSummary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience…
-
ChemIntelligenceCovid DrugsModerna
Moderna Projects COVID-19 Vaccine Sales at $19 Billion for 2022
by adminSummary : Moderna only has a single marketed product, but it’s a blockbuster, for now…
-
Centers for Disease Control and Prevention recommendedChemIntelligenceCovid Drugs
US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021
by adminSummary : The success of mRNA vaccines against COVID-19 has become a cash cow for…
-
ChemIntelligencePharma Science & Research
Research Collab Uncovers Underlying Mechanism for ALS and Dementia
by adminSummary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia…
-
Summary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced…
-
Global Market
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
by adminSummary : LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced…
-
ChemIntelligence
American Oncology Network (AON) and VieCure Announce Strategic Collaboration to Accelerate Adoption of Precision Oncology and Personalized Cancer Care
by adminSummary : Collaboration offers clinicians access to a state-of-the-art, cloud based oncology decision support platform…
-
ChemIntelligenceGlobal Market
Gunze Launches TENALEAF™ Absorbable Adhesion Barrier in Japan
by adminSummary : Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) [TOKYO: 3002] is pleased to…
Newer Posts